Trials / Unknown
UnknownNCT05786807
Effect of H. Pylori Eradication on Alleviating Symptoms in Functional Dyspepsia Patients
Effect of H. Pylori Eradication on Alleviating Symptoms in Functional Dyspepsia Patients: A Multicenter, Comparative Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 315 (estimated)
- Sponsor
- Wonkwang University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
In patients with Helicobacter pylori-positive functional dyspepsia, long-term follow-up for 6 months after standard triple therapy first-line eradication treatment, the rate of symptom disappearance and degree of improvement of functional dyspepsia were confirmed through changes in symptom scores and changes in drug usage, and eradication treatment The purpose of this study is to confirm the rate of symptom disappearance according to the results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K-CAB | Tegoprazan 50 mg 1 tab twice daily Amoxicillin 500mg 2 cap twice daily Clarithromycin 500mg 1tab twice daily |
Timeline
- Start date
- 2022-03-07
- Primary completion
- 2023-11-30
- Completion
- 2023-12-31
- First posted
- 2023-03-28
- Last updated
- 2023-03-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05786807. Inclusion in this directory is not an endorsement.